Cite

HARVARD Citation

    Arakawa, S. et al. (2021). RB1 loss induced small cell lung cancer transformation as acquired resistance to pembrolizumab in an advanced NSCLC patient. Lung cancer. pp. 101-103. [Online]. 
  
Back to record